Intravitreal autologous bone marrow cd34+ cell therapy for ischemic and degenerative retinal disorders: Preliminary phase 1 clinical trial findings

Research output: Contribution to journalArticlepeer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'Intravitreal autologous bone marrow cd34+ cell therapy for ischemic and degenerative retinal disorders: Preliminary phase 1 clinical trial findings'. Together they form a unique fingerprint.

Medicine & Life Sciences